WF International Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K report covers the month of June 2026, with a specific reporting date of June 26, 2026. WF International Ltd., a foreign private issuer headquartered in Chengdu, Sichuan, China, filed this report to disclose unregistered sales of equity securities and related agreements.
Key Financial Metrics and Transactions
The filing details a private placement transaction rather than standard operating financial results. Key transaction metrics include:
- Capital Raised: $2,000,000 aggregate purchase price.
- Shares Issued: 1,680,671 ordinary shares.
- Price Per Share: $1.19.
- Transaction Fees: $80,000 cash fee paid to placement agents.
- Additional Consideration: 20,000 unregistered ordinary shares issued to placement agents.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity positions for the period.
Material Changes and Agreements
On June 24, 2026, the Company entered into a Share Purchase Agreement for the private placement described above, with an anticipated closing on or about June 26, 2026. Concurrently, on June 23, 2026, the Company executed a Waiver Agreement with placement agents The Benchmark Company, LLC and Axiom Capital Management, Inc. This agreement waived the agents' right of first refusal (ROFR) for future offerings for a 12-month period following a November 2025 offering.
A significant material change involves the reduction of warrant exercise prices. The Company agreed to reduce the exercise price of warrants issued to placement agents and investors from $25.00 and $3.8671 per share, respectively, to $1.19 per share, aligning them with the new private placement price.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or an outlook for future periods. The primary risk disclosed relates to the dilution of existing shareholders due to the issuance of new shares and the reduction of warrant exercise prices, which increases the potential number of shares issuable upon exercise. The transaction was conducted pursuant to Regulation S under the Securities Act of 1933.
Investor Verification Checklist
- Verify the final closing date and receipt of the $2,000,000 proceeds from the private placement.
- Confirm the exact number of shares issued to placement agents as part of the waiver consideration.
- Review the updated capitalization table to assess the dilution impact of the 1,680,671 new shares and the reduced warrant exercise prices.
- Examine the full text of the Share Purchase Agreement (Exhibit 10.1) for any restrictive covenants or investor rights.
- Check subsequent filings for any updates on the company's liquidity position post-transaction.